 
        Dr  
        Stephen  
        Angeloni  
        
        Dr  
        Stephen  
        Angeloni  
        Interim Director of LuminexPlore Lab  
        Luminex Corp.  
Biography
        I received my PhD in Biochemistry from Virginia Polytechnic Inst. and State University.  I have been at Luminex for 14 years.  Before joining Luminex I had over 30 years of research and industry experience with the development of a wide variety of biochemical, genetic, proteomic, immunology, microscopy, cellular, molecular biology assays and bioinformatic tools.  These technologies were applied to studying genetic and environmental factors contributing to the susceptibility or resistance to a number of infectious and non-infectious diseases.  This includes studies on disease mechanisms or treatments in the areas of endocrinology, cancer, obesity, diabetes and the development of DNA vaccines.  These research efforts employed cellular, mouse and non-human primate model systems.  This diversified experience has been applied to developing and supporting commercial applications for cellular genetic engineering, bioinformatic data analysis as well the development of genomic and proteomic assay platforms for research and diagnostics.  This experience is now available for supporting the development of several applications on the Luminex xMAP platform.  Research interests
        Mainly development of multiplex assays for studying vaccine efficacy, pathogen titer detection, pathogen detection, and effectiveness of other therapeutics.  Projects you're working on
        Making different multiplex assays for pathogen detection and monitoring vaccine effectiveness in animals and humans.  Discipline
        Bioinformatics      Cellular biology      Challenge model development      Commercialisation      Deployment      Epidemiology      Immunology – innate      Molecular biology      Protein biology      Virology  Host species
        Buffalo      Camels      Cats      Cattle      Dogs      Horses      Pigs      Poultry      Small ruminants      Wildlife  Pathogen
        Viruses  Stage of vaccine development
        Antigen discovery and immunogen design      Correlates of protection – immunomonitoring      Deployment      Field trials      Pre-clinical trials